Role of rosuvastatin in current lipid-lowering therapy

Statins are the most widely used lipid-lowering therapy. Among them, the rosuvastatin can be well tolerated and effectively helps to reach LDL-cholesterol goals in primary and secondary cardiovascular prevention. In addition, rosuvastatin reduces triglyceride and high-sensitivity C-reactive protein...

Full description

Saved in:
Bibliographic Details
Published inOrvosi hetilap Vol. 151; no. 35; p. 1424
Main Authors Abel, Tatjána, Fehér, János
Format Journal Article
LanguageHungarian
Published Hungary 29.08.2010
Subjects
Acute Coronary Syndrome - blood
Acute Coronary Syndrome - drug therapy
Acute Coronary Syndrome - prevention & control
Atherosclerosis - blood
Atherosclerosis - drug therapy
Atherosclerosis - etiology
Atherosclerosis - prevention & control
C-Reactive Protein - drug effects
C-Reactive Protein - metabolism
Cholesterol - blood
Disease Progression
Fluorobenzenes - therapeutic use
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Hypercholesterolemia - blood
Hypercholesterolemia - complications
Hypercholesterolemia - drug therapy
Meta-Analysis as Topic
Pyrimidines - therapeutic use
Rosuvastatin Calcium
Sulfonamides - therapeutic use
Online AccessGet more information

Cover

More Information
Summary:Statins are the most widely used lipid-lowering therapy. Among them, the rosuvastatin can be well tolerated and effectively helps to reach LDL-cholesterol goals in primary and secondary cardiovascular prevention. In addition, rosuvastatin reduces triglyceride and high-sensitivity C-reactive protein level and increases high-density lipoprotein (HDL) cholesterol, too. Imaging studies demonstrated that rosuvastatin therapy can not only reduce atherosclerosis progression but might induce its regression too.
ISSN:0030-6002
DOI:10.1556/OH.2010.28937